Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss Nable Inc NABL Q1 2026 Earnings EPS Misses Estimates Despite Narrow Gap Stock Gains 28 ELTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline KHC Q1 2026 Earnings EPS Surges Past Estimates Amid Cost Discipline DBI Q1 2026 Earnings Narrower Loss Beats Estimates Shares Rally Over 6 DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline